Photo by Westlake Village BioPartners
Photo from Beth Seidenberg on Twitter

Beth Seidenberg

Physician, Managing Director, Investor

Westlake Village BioPartners


Physician, Managing Director, Investor


Westlake Village BioPartners




Westlake Village BioPartners






What makes Beth Seidenberg a Global Shaker?

Dr. Beth Seidenberg is the founder and managing director of Westlake Village BioPartners. She spent 14 years at Kleiner Perkins Caufield & Byers, serving as a general partner with a focus on life science investing. She’s one of the top women in venture capital in the world, placing at #59 on the 2019 Forbes’ Midas List.

She has incubated and invested in 15 biotech ventures since 2006, including: Arresto (sold to Gilead in 2011), which focused on developing antibody therapeutics for cancer and fibrosis; 3-V Biosciences, which focused on therapeutics for infectious diseases; Auxogyn, which focused on diagnostics and devices for in-vitro fertilization; Epizyme, which focused on therapeutics based on epigenetic targets; and iPierian, which focused on drug discoveries for neurodegenerative disorders using induced pluripotent stem cells (iPS).

She also played a pivotal role in several significant exits for Kleiner Perkins: Flexus Biosciences, which was acquired by Bristol-Myers Squibb for $1.25 billion; TrueNorth Therapeutics, a rare disease biotechnology company that was sold to Bioverativ for $400 million; and Tesaro, an oncology-focused drug producer that was acquired for over $5 billion.

In September 2018, she launched Westlake Village BioPartners with $320 million of capital. The firm’s mission is to assist those with an entrepreneurial spirit and passion “push the boundaries of science and technology.”

Beth is a physician by trade. Prior to pursuing life science investing, she developed treatments for AIDS, arthritis, asthma, cancer and psoriasis, cardiovascular, metabolic, neurological and renal disorders for over two decades, introducing 10 innovative products to market.

Beth has a bachelor’s in biology and anthropology from Barnard College and received her MD degree at the University of Miami School of Medicine. She completed her residency at Johns Hopkins University and George Washington University and a fellowship at the National Institutes of Health.

Tags: biotechnology, STEM, VC, Women in VC

Last updated: July 15, 2019